Search results
Found 9898 matches for
Researchers have uncovered how tumors exploit tenascin-C to deflect the body’s natural defence against them.
©
Shutterstock
Our DPhil students
Our world-leading translational science driven by exceptional DPhil students.
MEET THE TEAM
-
Kim Midwood
Kennedy Director of Graduate Studies
Matrix-targeting immunotherapy controls tumor growth and spread by switching macrophage phenotype
Cancer Immunology Research
Our research themes
Similar stories
EPSRC fellowship awarded to Huw Colin-York
4 July 2023
Huw Colin-York has been awarded a fellowship from the Engineering and Physical Sciences Research Council (EPSRC) to develop synthetic biology tools to understand the immune response.